Una variante del gen GLP1R (glucagon-like peptide-1 receptor), diana de varios tratamientos para la diabetes mellitus, se ha asociado con menor riesgo de enfermedad coronaria. Los detalles aparecen en Scott RA, Freitag DF, Li L, Chu AY, Surendran P, Young R, et al. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. Science Translational Medicine 01 Jun 2016;8(341):341ra76.
Gen protector para cardiopatía isquémica
Filed under Cardiopatías, Diagnóstico, Medicina personalizada, Polimorfismos by on .
You must be logged in to post a comment. Login.
Leave a Comment